Stockreport

Sarepta Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]

Sarepta Therapeutics, Inc.  (SRPT) 
Last sarepta therapeutics, inc. earnings: 2/26 04:05 pm Check Earnings Report
PDF million ) and guided 2026 approved-therapy revenue to roughly $1.2 billion to $1.4 billion , while ending 2025 with $954 million in cash and expecting unit-volume margin [Read more]